File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

TitleManagement and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Authors
KeywordsHypertension
IgA nephropathy
KDIGO
Kidney biopsy
Membranous nephropathy
Proteinuria
Issue Date2019
PublisherElsevier for International Society of Nephrology. The Journal's web site is located at http://www.kidney-international.org
Citation
Kidney International, 2019, v. 95 n. 2, p. 268-280 How to Cite?
AbstractThe Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.
Persistent Identifierhttp://hdl.handle.net/10722/275095
ISSN
2019 Impact Factor: 8.945
2015 SCImago Journal Rankings: 3.181
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFloege, J-
dc.contributor.authorBarbour, SJ-
dc.contributor.authorCattran, DC-
dc.contributor.authorHogan, JJ-
dc.contributor.authorNachman, PH-
dc.contributor.authorTang, SCW-
dc.contributor.authorWetzels, JFM-
dc.contributor.authorCheung, M-
dc.contributor.authorWheeler, DC-
dc.contributor.authorWinkelmayer, WC-
dc.contributor.authorRovin, BH-
dc.contributor.authorAdler, SG-
dc.contributor.authorAlpers, CE-
dc.contributor.authorAyoub, I-
dc.contributor.authorBagga, A-
dc.contributor.authorBarratt, J-
dc.contributor.authorCaster, DJ-
dc.contributor.authorChan, DTM-
dc.contributor.authorChang, A-
dc.contributor.authorChoo, JCJ-
dc.contributor.authorCook, HT-
dc.contributor.authorCoppo, R-
dc.contributor.authorFervenza, FC-
dc.contributor.authorFogo, AB-
dc.contributor.authorFox, JG-
dc.contributor.authorGibson, KL-
dc.contributor.authorGlassock, RJ-
dc.contributor.authorHarris, D-
dc.contributor.authorHodson, EM-
dc.contributor.authorHoxha, E-
dc.contributor.authorIseki, K-
dc.contributor.authorJennette, JC-
dc.contributor.authorJha, V-
dc.contributor.authorJohnson, DW-
dc.contributor.authorKaname, S-
dc.contributor.authorKatafuchi, R-
dc.contributor.authorKitching, AR-
dc.contributor.authorLafayette, RA-
dc.contributor.authorLi, PKT-
dc.contributor.authorLiew, A-
dc.contributor.authorLv, J-
dc.contributor.authorMalvar, A-
dc.contributor.authorMaruyama, S-
dc.contributor.authorMejía-Vilet, JM-
dc.contributor.authorMoeller, MJ-
dc.contributor.authorMok, CC-
dc.contributor.authorNester, CM-
dc.contributor.authorNoiri, E-
dc.contributor.authorO'Shaughnessy, MM-
dc.contributor.authorÖzen, S-
dc.contributor.authorParikh, SM-
dc.contributor.authorPark, HC-
dc.contributor.authorPeh, CA-
dc.contributor.authorPendergraft, WF-
dc.contributor.authorPickering, MC-
dc.contributor.authorPillebout, E-
dc.contributor.authorRadhakrishnan, J-
dc.contributor.authorRathi, M-
dc.contributor.authorRoccatello, D-
dc.contributor.authorRonco, P-
dc.contributor.authorSmoyer, WE-
dc.contributor.authorTesař, V-
dc.contributor.authorThurman, JM-
dc.contributor.authorTrimarchi, H-
dc.contributor.authorVivarelli, M-
dc.contributor.authorWalters, GD-
dc.contributor.authorWang, AYM-
dc.contributor.authorWenderfer, SE-
dc.date.accessioned2019-09-10T02:35:21Z-
dc.date.available2019-09-10T02:35:21Z-
dc.date.issued2019-
dc.identifier.citationKidney International, 2019, v. 95 n. 2, p. 268-280-
dc.identifier.issn0085-2538-
dc.identifier.urihttp://hdl.handle.net/10722/275095-
dc.description.abstractThe Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline’s publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.-
dc.languageeng-
dc.publisherElsevier for International Society of Nephrology. The Journal's web site is located at http://www.kidney-international.org-
dc.relation.ispartofKidney International-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectHypertension-
dc.subjectIgA nephropathy-
dc.subjectKDIGO-
dc.subjectKidney biopsy-
dc.subjectMembranous nephropathy-
dc.subjectProteinuria-
dc.titleManagement and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference-
dc.typeArticle-
dc.identifier.emailTang, SCW: scwtang@hku.hk-
dc.identifier.emailChan, DTM: dtmchan@hkucc.hku.hk-
dc.identifier.emailWang, AYM: aymwang@HKUCC-COM.hku.hk-
dc.identifier.authorityTang, SCW=rp00480-
dc.identifier.authorityChan, DTM=rp00394-
dc.identifier.authorityWang, AYM=rp02174-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.kint.2018.10.018-
dc.identifier.pmid30665568-
dc.identifier.scopuseid_2-s2.0-85059848558-
dc.identifier.hkuros303447-
dc.identifier.volume95-
dc.identifier.issue2-
dc.identifier.spage268-
dc.identifier.epage280-
dc.identifier.isiWOS:000456166100009-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats